Table 1.
Patient Characteristics
| disease state | stage | gleason score | tumor volume (cm3) | Risk/disease | psa |
|---|---|---|---|---|---|
| Benign | na | na | 0 | PIN | 0 |
| na | na | 0 | BPH | 0 | |
| na | na | 0 | BPH | 4.6 | |
| na | na | 0 | BPH | 0 | |
| na | na | 0 | BPH | 0 | |
| na | na | 0 | BPH | 4.6 | |
| na | na | 0 | N | 1.8 | |
| na | na | 0 | N | 0 | |
| na | na | 0 | PIN | 3.7 | |
| na | na | 0 | BPH | 3.1 | |
| na | na | 0 | N | 6.8 | |
| na | na | 0 | N | 4.2 | |
| na | na | 0 | N | 9.4 | |
| na | na | 0 | N | 10.5 | |
| na | na | 0 | PIN | 23.4 | |
| Low-risk | T2c | 3+3 | 0 | L | 5.7 |
| CT2ANXMX | 3+3 | 0 | L | 4.2 | |
| CT2ANXMX | 3+3 | 0 | L | 2.5 | |
| CT1CNXMX | 3+3 | 0 | L | 1.8 | |
| CT1CNXMX | < 6 | 0 | L | 2.6 | |
| CT1CNXMX | 3+3 | 0 | L | 3.5 | |
| CT2ANXMX | 3+3 | 0 | L | 7.93 | |
| CT1CNXMX | 3+3 | 0 | L | 4.52 | |
| T2c | 3+3 | 0 | L | 3.4 | |
| T2c | 3+4 | 0 | L | 2.3 | |
| T2c | 3+3 | 0 | L | 9.8 | |
| CT1CNXMX | 3+3 | 0 | L | 11.1 | |
| Intermediate/High-risk | Unknown | 3+4 | 0 | I | 8.8 |
| T2c | 4+3 | 15 | I | 2.6 | |
| T2c | 4+3 | 0 | I | 4.9 | |
| T2a | 4+4 | 2 | H | 6.1 | |
| T2c | 4+4 | 7 | H | 0 | |
| T3a | 3+4 | 25 | H | 0 | |
| CT2ANXMX | 4+4 | 0 | H | 26.6 | |
| CT1CNXMX | 4+5 | 0 | H | 0.2 | |
| CT3BNXMX | 4+3 | 0 | H | 0 | |
| CT3BNXMX | 4+3 | 0 | H | 0 | |
| CT2BNXMX | 4+5 | 0 | H | 0.72 | |
| CT2CNXMX | 5+5 | 0 | H | 65.7 |